Israeli biopharma company Teva Pharmaceutical Industries Limited (TEVA) is set to replace its American Depository Shares (ADSs) with the direct listing of its ordinary shares on the NYSE. We take a closer look at Teva Pharmaceutical before that happens. More News from BarchartAbout Teva Pharmaceutical StockTeva Pharmaceutical Industries is a global biopharmaceutical company known for its large generics business and growing portfolio of innovative medicines. Over the past 52 weeks, Teva's stock has gained 108%, while it is up 12.2% year-to-date (YTD). Teva Pharmaceutical Leans on Branded-Drug Momentum to Boost Q2 Results and Outlook